Canadian Cancer Trials Group Bulletins

Trial Management Group


Trial Closures

Canadian Cancer Trials Group SC.22 -- A Phase I Study to Determine the Dose of Methadone as a First Line Agent in the Treatment of Chronic Neuropathic Cancer Pain

Please be advised that Canadian Cancer Trials Group SC.22 was closed to accrual on Monday, May 16, 2011. Accrual to this trial failed to meet the specified targets and the DSMC recommended that it be closed.

Canadian Cancer Trials Group PR.11 -- A Phase III Study of Active Surveillance Therapy Against Radical Treatment in Patients Diagnosed with Favourable Risk Prostate Cancer

Please be advised that Canadian Cancer Trials Group PR.11 was closed to accrual on Friday, May 13, 2011. This trial had not met its accrual targets and the recommendation for closure came from the DSMC.

In the next few weeks, the trial committee will decide upon the duration of patient follow-up and data collection for patients already randomized to this trial, and this information will be communicated to participating centres.

We are very grateful for the efforts of all of those involved with these trials.